These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15817174)

  • 21. Manual transport in Parkinson's disease.
    Hejduková B; Hosseini N; Johnels B; Ingvarsson PE; Steg G; Olsson T
    Mov Disord; 2003 May; 18(5):565-72. PubMed ID: 12722171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
    Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
    Plotnik M; Giladi N; Hausdorff JM
    Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective memory and mesial temporal epilepsy associated with hippocampal sclerosis.
    Adda CC; Castro LH; Além-Mar e Silva LC; de Manreza ML; Kashiara R
    Neuropsychologia; 2008; 46(7):1954-64. PubMed ID: 18329672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body side of motor symptom onset in Parkinson's disease is associated with memory performance.
    Amick MM; Grace J; Chou KL
    J Int Neuropsychol Soc; 2006 Sep; 12(5):736-40. PubMed ID: 16961953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative study of salivary secretion in Parkinson's disease.
    Tumilasci OR; Cersósimo MG; Belforte JE; Micheli FE; Benarroch EE; Pazo JH
    Mov Disord; 2006 May; 21(5):660-7. PubMed ID: 16419045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment.
    Righi S; Viggiano MP; Paganini M; Ramat S; Marini P
    Neuropsychologia; 2007 Oct; 45(13):2931-41. PubMed ID: 17662314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
    Lucetti C; Gambaccini G; Del Dotto P; Ceravolo R; Logi C; Rossi G; Murri L; Bonuccelli U
    Parkinsonism Relat Disord; 2006 Jun; 12(5):279-83. PubMed ID: 16549382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Parkinson's disease on time estimation as a function of stimulus duration range and modality.
    Smith JG; Harper DN; Gittings D; Abernethy D
    Brain Cogn; 2007 Jul; 64(2):130-43. PubMed ID: 17343966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS; Lou JS; Eaton R; Nutt J
    Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.